Effect of Valerian on depression, anxiety, stress of employed midwives

A comparative Study of Valerian consumption in different course on anxiety stress and depression of employed midwives

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20130211012440N7

Enrollment

Registered

2019-09-06

Start date

2019-10-23

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Anxiety. Condition 2: depression. Condition 3: stress. Other anxiety disorders Other depressive episodes Other physical and mental strain related to work

Interventions

Intervention 1: Intervention group: (530 mg Valerian capsule) containing the roots of Valerian (manufactured by Flower Drug Company) purchased in Iran 2 times daily for one month. Intervention 2: Cont

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Inclusion criteria: 1-No use of sedatives and Hypnotic 2- Having mild to moderate anxiety 3- No known mental illness.

Exclusion criteria

Exclusion criteria: Exclusion criteria: 1-Failure to complete the questionnaire and daily and timely consumption of Sedamin's capsule 2-pregnancy.

Design outcomes

Primary

Measure	Time frame
Depression Score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.;Anxiety score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.;Anxiety Score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.;Sress score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.	—

Measure

Time frame

Depression Score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.;Anxiety score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.;Anxiety Score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.;Sress score. Timepoint: Before the intervention, one week after the intervention, one month after the intervention. Method of measurement: Dass_21 Questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public Contactsyede faeze hashemi nezhad

Tehran University of Medical Sciences

56136513ff@gmail.com+98 21 8893 3768

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026